| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ch. Discov. &Non-clin Dev Off | Chief Development Officer | Chief Development Officer
1 company
Myles David C. is a Ch. Discov. &Non-clin Dev Off at Olema Pharmaceuticals, Inc.. Recent SEC Form 4 filings include 0 buys and 20 sells.
Estimated insider holdings value: $8.3M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 14, 2026 | OLMA Olema Pharmaceuticals, Inc. | Ch. Discov. &Non-clin Dev Off | Sale+OE | 110,000 | $28.25 | $3,107,229.17 | -4.5% | -44.0% | - | |
| Dec 19, 2025 | OLMA Olema Pharmaceuticals, Inc. | Ch. Discov. &Non-clin Dev Off | Sell | 51,000 | $30.46 | $1,553,543.54 | -2.9% | -46.4% | - | |
| Dec 11, 2024 | OLMA Olema Pharmaceuticals, Inc. | Ch. Discov. &Non-clin Dev Off | Sell | 26,066 | $9.01 | $234,916.00 | -1.4% | -48.5% | +275.5% | |
| Nov 22, 2023 | OLMA Olema Pharmaceuticals, Inc. | Ch. Discov. &Non-clin Dev Off | Sell | 13,629 | $14.40 | $196,233.29 | -0.8% | +4.3% | -42.8% | |
| Nov 8, 2023 | OLMA Olema Pharmaceuticals, Inc. | Ch. Discov. &Non-clin Dev Off | Sell | 200 | $17.61 | $3,522.00 | - | -9.6% | -27.7% | |
| Nov 3, 2023 | OLMA Olema Pharmaceuticals, Inc. | Ch. Discov. &Non-clin Dev Off | Sell | 10,541 | $15.26 | $160,805.79 | -0.6% | -8.1% | -30.0% | |
| Sep 19, 2023 | OLMA Olema Pharmaceuticals, Inc. | Ch. Discov. &Non-clin Dev Off | Sell | 20,000 | $12.67 | $253,400.00 | -3.4% | +3.2% | +1.3% | |
| Dec 10, 2021 | OLMA Olema Pharmaceuticals, Inc. | Chief Development Officer | Sell | 10,000 | $10.30 | $103,000.00 | -1.7% | -54.1% | -76.1% |